Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06878027 | Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool | recruiting | — | 100 | Regina Elena Cancer InstituteOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT04510129 | A Multicenter Cancer Biospecimen Collection Study | recruiting | — | 1,650 | Cofactor Genomics, Inc.INDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06863844 | The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor(PROCURO) | recruiting | — | 210 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT05231655 | Ex VIvo DEtermiNed Cancer Therapy(EVIDENT) | recruiting | — | 600 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06493370 | Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer | recruiting | Phase 2 | 48 | University of Kansas Medical CenterOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06696794 | Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients | recruiting | Phase 3 | 180 | Shaogang WangOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06337942 | Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study | recruiting | N/A | 5 | University of California, Los AngelesOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06281080 | First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours | recruiting | N/A | 10 | Chinese University of Hong KongOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06775977 | Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer(UCEADP-BCS) | recruiting | — | 480 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT05917158 | A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma(1) | recruiting | Phase 2 | 30 | Jinling Hospital, ChinaOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT04724928 | Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer(EFFORT-MIBC) | recruiting | Phase 2 | 156 | University Hospital, GhentOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06186414 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC | recruiting | Phase 1 | 152 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 15, 2025 | clinicaltrials |
| NCT05204108 | Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography | recruiting | — | 1,000 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06732531 | Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer | recruiting | Phase 1 / Phase 2 | 48 | Zhuhai Beihai Biotech Co., LtdINDUSTRY | 1 | Jan 9, 2025 | clinicaltrials |
| NCT05790850 | Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)(PRIMER) | recruiting | N/A | 30 | University of VirginiaOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06719232 | Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation(NOCATIN) | recruiting | — | 300 | Jahn Ferenc South Pest Teaching HospitalOTHER_GOV | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06679920 | Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment(BLOCT) | recruiting | N/A | 15 | Amsterdam UMCOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT04861584 | Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects | recruiting | Phase 2 | 41 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT05067101 | Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer | recruiting | N/A | 126 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06341400 | RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients | recruiting | Phase 1 / Phase 2 | 55 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT05453682 | Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)(HIRACOM) | recruiting | N/A | 53 | Samsung Medical CenterOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT06632262 | A Phase 2 Clinical Study of ABSK061 and ABSK043 | recruiting | Phase 2 | 202 | Abbisko Therapeutics Co, LtdINDUSTRY | 1 | Nov 19, 2024 | clinicaltrials |
| NCT06639347 | A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma | recruiting | Phase 1 / Phase 2 | 90 | Shanghai Hengrui Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 18, 2024 | clinicaltrials |
| NCT06598761 | Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC | recruiting | — | 60 | Peking University First HospitalOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT05969964 | Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins | recruiting | — | 370 | Mansoura UniversityOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06662071 | A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology | recruiting | — | 293 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 28, 2024 | clinicaltrials |
| NCT06652009 | Radical Radiotherapy Versus Radical Surgery for UTUC | recruiting | — | 60 | Peking University First HospitalOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT06652022 | Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs | recruiting | N/A | 102 | Peking University First HospitalOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT04979156 | LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors(LaserEn) | recruiting | — | 20 | University of Kansas Medical CenterOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT05203913 | Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer(CNN-BC) | recruiting | Phase 2 | 32 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT05878964 | Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.(SkinHealth) | recruiting | — | 420 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT05153694 | Infectious Complications After Cystectomy: A Prospective Observational Study | recruiting | — | 200 | Ludwig-Maximilians - University of MunichOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06079112 | 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer | recruiting | Phase 1 / Phase 2 | 100 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06592326 | 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer | recruiting | Phase 3 | 460 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT06474338 | AI Detection of Bladder Tumors Under Endoscopy | recruiting | — | 1,000 | Peking Union Medical College HospitalOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05739968 | Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients | recruiting | N/A | 120 | National Taiwan University HospitalOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06441110 | Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer | recruiting | Phase 3 | 76 | Fujian Medical University Union HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05397262 | Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia(HyBla_RCT) | recruiting | N/A | 1,000 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06357416 | The Man Van Project(MV) | recruiting | N/A | 4,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT04641936 | Urine Omics Predicting IO Therapy Responses in mUC Patients | recruiting | — | 600 | National Taiwan University HospitalOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06354231 | DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC | recruiting | Phase 2 | 20 | Fudan UniversityOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06341478 | Investigator Grant (IG) 2022 27746 | recruiting | N/A | 153 | IRCCS San RaffaeleOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT03973671 | Prospective Sample Collection for Cancer of Bladder(ProCaB) | recruiting | — | 300 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT06269536 | Stress-reducing Intervention in Urothelial Carcinoma | recruiting | N/A | 50 | Comenius UniversityOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT05731622 | Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC(SINCERE) | recruiting | — | 100 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05302284 | A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma | recruiting | Phase 3 | 452 | RemeGen Co., Ltd.INDUSTRY | 1 | Dec 18, 2023 | clinicaltrials |
| NCT06170177 | Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy | recruiting | — | 4,000 | IRCCS San RaffaeleOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT06169436 | Translational Cancer Observational Protocol | recruiting | — | 1,250 | IRCCS San RaffaeleOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06167356 | Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. | recruiting | — | 20,000 | IRCCS San RaffaeleOTHER | 1 | Dec 12, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 14, 2025source: clinicaltrials